BERWYN, PA — AMETEK Inc. (NYSE: AME) raised its full-year earnings outlook after second-quarter adjusted profit climbed 17% and orders surged 28%, signaling continued demand across semiconductor, aerospace, defense, medical technology and automation markets.
The industrial technology company now expects adjusted earnings of $8.20 to $8.30 per diluted share in 2026, up 10% to 12% from the comparable 2025 level. Its previous forecast called for $7.94 to $8.14 per share.
AMETEK (NYSE: AME) also expects full-year sales to increase about 10% from 2025.
Second-quarter sales rose 15% to a record $2.04 billion. Adjusted earnings reached $2.09 per diluted share, compared with the year-earlier period’s $1.79 per share.
On a GAAP basis, diluted earnings were $1.77 per share. The adjusted figure excludes $0.32 per share of after-tax acquisition-related intangible amortization, financing fees and integration costs.
GAAP operating income totaled $528.2 million. Adjusted operating income increased 18% to $544.4 million, while the adjusted operating margin expanded 60 basis points from a year earlier to 26.6%.
Operating cash flow increased 35% to $483.7 million. AMETEK reported free cash flow equal to 111% of net income during the quarter.
Orders rose 28%, marking a second consecutive quarter of strong order growth, according to Chairman and Chief Executive Officer David A. Zapico.
“Strong organic sales growth, contributions from recent acquisitions, and outstanding operating performance led to high-teens earnings growth,” Zapico stated.
AMETEK’s Electronic Instruments Group generated $1.32 billion in sales, up 14% from the second quarter of 2025. GAAP operating income was $369.8 million, while adjusted operating income increased 12% to $384.7 million.
The segment benefited from both organic growth and acquisitions, with order strength particularly concentrated in semiconductor and commercial aerospace markets. Core operating margins rose 40 basis points to 30.1%.
The Electromechanical Group posted record sales of $723.2 million, up 17% from a year earlier.
GAAP operating income for the segment was $189.3 million. Adjusted operating income jumped 32% to a record $190.5 million, producing an operating margin of 26.3%.
AMETEK attributed the segment’s order growth to broad demand, including strength in medical technology, defense and automation markets. Core margins expanded 290 basis points.
For the third quarter, AMETEK expects sales to increase by a high-single-digit percentage from the same period in 2025. Adjusted earnings are projected at $2.08 to $2.10 per diluted share, representing growth of 10% to 11%.
The higher full-year forecast reflects the company’s second-quarter performance and expectations for the remainder of 2026, Zapico stated.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.